User profiles for "author:Guilherme H Oliveira"

Guilherme H Oliveira

Professor of Medicine, University of South Florida
Verified email at usf.edu
Cited by 4893

Cardio-oncology training: a proposal from the International Cardioncology Society and Canadian Cardiac Oncology Network for a new multidisciplinary specialty

DJ Lenihan, G Hartlage, J DeCara, A Blaes… - Journal of cardiac …, 2016 - Elsevier
There is an increasing awareness and clinical interest in cardiac safety during cancer
therapy as well as in optimally addressing cardiac issues in cancer survivors. Although there …

Effects of liraglutide on clinical stability among patients with advanced heart failure and reduced ejection fraction: a randomized clinical trial

KB Margulies, AF Hernandez, MM Redfield, MM Givertz… - Jama, 2016 - jamanetwork.com
Importance Abnormal cardiac metabolism contributes to the pathophysiology of advanced
heart failure with reduced left ventricular ejection fraction (LVEF). Glucagon-like peptide 1 …

Prevalence and outcomes of unoperated patients with severe symptomatic mitral regurgitation and heart failure: comprehensive analysis to determine the potential …

SS Goel, N Bajaj, B Aggarwal, S Gupta… - Journal of the American …, 2014 - jacc.org
To the Editor: Mitral valve (MV) surgery is recommended in patients with severe symptomatic
mitral regurgitation (MR)(1). The role of MV surgery is unclear in patients with severe MR …

Effect of treatment with sacubitril/valsartan in patients with advanced heart failure and reduced ejection fraction: a randomized clinical trial

DL Mann, MM Givertz, JM Vader, RC Starling… - JAMA …, 2022 - jamanetwork.com
Importance The use of sacubitril/valsartan is not endorsed by practice guidelines for use in
patients with New York Heart Association class IV heart failure with a reduced ejection …

Simultaneous venoarterial extracorporeal membrane oxygenation and percutaneous left ventricular decompression therapy with Impella is associated with improved …

SM Patel, J Lipinski, SG Al-Kindi, T Patel, P Saric… - ASAIO …, 2019 - journals.lww.com
Venoarterial extracorporeal membrane oxygenation (VA-ECMO) has been used for
refractory cardiogenic shock; however, it is associated with increased left ventricular …

Heart failure in systemic lupus erythematosus

BP Dhakal, CH Kim, SG Al-Kindi, GH Oliveira - Trends in cardiovascular …, 2018 - Elsevier
Systemic lupus erythematosus (SLE) is an autoimmune disorder characterized by a
constellation of cardiovascular (CV) and non-CV manifestations. Even though CV …

Heart transplantation for Chagas cardiomyopathy

RD Benatti, GH Oliveira, F Bacal - The Journal of Heart and Lung …, 2017 - Elsevier
Chagas cardiomyopathy (CC) is one of the chronic manifestations of Trypanosoma cruzi (T.
cruzi) infection and is a major public health disease in Latin America. Since it is a chronic …

Prevalence of preexisting cardiovascular disease in patients with different types of cancer: the unmet need for onco-cardiology

SG Al-Kindi, GH Oliveira - Mayo Clinic Proceedings, 2016 - Elsevier
Cancer and cardiovascular diseases (CVDs) share many of the same risk factors. Using a
cloud-based health care database, we identified patients with malignancies that often …

Characteristics and survival of malignant cardiac tumors: a 40-year analysis of> 500 patients

GH Oliveira, SG Al-Kindi, C Hoimes, SJ Park - Circulation, 2015 - Am Heart Assoc
Background—The aim of this study was to investigate the incidence, histopathology,
demographics, and survival associated with primary malignant cardiac tumors (PMCTs) …

Increased need for right ventricular support in patients with chemotherapy-induced cardiomyopathy undergoing mechanical circulatory support: outcomes from the …

GH Oliveira, M Dupont, D Naftel, SL Myers… - Journal of the American …, 2014 - jacc.org
Objectives: The aim of this study was to investigate the use of durable mechanical circulatory
support (MCS) in patients with chemotherapy-induced cardiomyopathy (CCMP) and …